Atlas Trials

AI-Enhanced Wide-Field Endoscopic Fluorescence Mapping of Gastrointestinal Mucosal Permeability in IBD - A Pilot Study in IBD Patients and Controls

Clinical trial NCT07546955 · NOT_YET_RECRUITING

Trial details

NCT number
NCT07546955
Sponsor
Hamilton Health Sciences Corporation
Status
NOT_YET_RECRUITING
Study type
OBSERVATIONAL
Inflammatory Bowel Disease (Crohn's Disease; Ulcerative Colitis)NON-IBD
Start date
2026-04-01
Primary completion
2027-02-01
Enrollment
70

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.